Cdk7: a kinase at the core of transcription and in the crosshairs of cancer drug discovery

References

• Fisher RP. Secrets of a double agent: CDK7 in cell-cycle control and transcription. J Cell Sci. 2005;118:5171–5180.
   PubMed Web of Science ®Google Scholar
• Ganuza M, Saiz-Ladera C, Canamero M, et al. Genetic inactivation of Cdk7 leads to cell cycle arrest and induces premature aging due to adult stem cell exhaustion. Embo J. 2012;31:2498–2510.
   PubMed Web of Science ®Google Scholar
• Larochelle S, Merrick KA, Terret ME, et al. Requirements for Cdk7 in the assembly of Cdk1/cyclin B and activation of Cdk2 revealed by chemical genetics in human cells. Mol Cell. 2007;25:839–850.
   PubMed Web of Science ®Google Scholar
• Kwiatkowski N, Zhang T, Rahl PB, et al. Targeting transcription regulation in cancer with a covalent CDK7 inhibitor. Nature. 2014;511:616–620.
   PubMed Web of Science ®Google Scholar
• Larochelle S, Amat R, Glover-Cutter K, et al. Cyclin-dependent kinase control of the initiation-to-elongation switch of RNA polymerase II. Nat Struct Mol Biol. 2012;19:1108–1115.
   PubMed Web of Science ®Google Scholar
• Espinoza FHE, Farrell A, Nourse JL, et al. Cak1 is required for Kin28 phosphorylation and activation in vivo. Mol Cell Biol. 1998;18:6365–6373.
   PubMed Web of Science ®Google Scholar
• Kimmelman J, Kaldis P, Hengartner CJ, et al. Activating phosphorylation of the kin28p subunit of yeast TFIIH by cak1p. Mol Cell Biol. 1999;19:4774–4787.
   PubMed Web of Science ®Google Scholar
• Ostapenko D, Solomon MJ. Phosphorylation by Cak1 regulates the C-terminal domain kinase Ctk1 in saccharomyces cerevisiae. Mol Cell Biol. 2005;25:3906–3913.
   PubMed Web of Science ®Google Scholar
• Pei Y, Du H, Singer J, et al. Cyclin-dependent kinase 9 (Cdk9) of fission yeast is activated by the CDK-activating kinase Csk1, overlaps functionally with the TFIIH-associated kinase Mcs6, and associates with the mRNA cap methyltransferase Pcm1 in vivo. Mol Cell Biol. 2006;26:777–788.
   PubMed Web of Science ®Google Scholar
• Yao S, Prelich G. Activation of the Bur1-Bur2 cyclin-dependent kinase complex by Cak1. Mol Cell Biol. 2002;22:6750–6758.
   PubMed Web of Science ®Google Scholar
• Akhtar MS, Heidemann M, Tietjen JR, et al. TFIIH kinase places bivalent marks on the carboxy-terminal domain of RNA polymerase II. Mol Cell. 2009;34:387–393.
   PubMed Web of Science ®Google Scholar
• Glover-Cutter K, Larochelle S, Erickson B, et al. TFIIH-associated Cdk7 kinase functions in phosphorylation of C-terminal domain Ser7 residues, promoter-proximal pausing, and termination by RNA polymerase II. Mol Cell Biol. 2009;29:5455–5464.
   PubMed Web of Science ®Google Scholar
• St Amour CV, Sanso M, Bosken CA, et al. Separate domains of fission yeast Cdk9 (P-TEFb) are required for capping enzyme recruitment and primed (Ser7-Phosphorylated) Rpb1 Carboxyl-terminal domain substrate recognition. Mol Cell Biol. 2012;32:2372–2383.
   PubMed Web of Science ®Google Scholar
• Bataille AR, Jeronimo C, Jacques PE, et al. A universal RNA polymerase II CTD cycle is orchestrated by complex interplays between kinase, phosphatase, and isomerase enzymes along genes. Mol Cell. 2012;45:158–170.
   PubMed Web of Science ®Google Scholar
• Tietjen JR, Zhang DW, Rodriguez-Molina JB, et al. Chemical-genomic dissection of the CTD code. Nat Struct Mol Biol. 2010;17:1154–1161.
   PubMed Web of Science ®Google Scholar
• Kanin EI, Kipp RT, Kung C, et al. Chemical inhibition of the TFIIH-associated kinase Cdk7/Kin28 does not impair global mRNA synthesis. Proc Natl Acad Sci U S A. 2007;104:5812–5817.
   PubMed Web of Science ®Google Scholar
• Nilson KA, Guo J, Turek ME, et al. THZ1 reveals roles for Cdk7 in co-transcriptional capping and pausing. Mol Cell. 2015;59:576–587.
   PubMed Web of Science ®Google Scholar
• Viladevall L, St Amour CV, Rosebrock A, et al. TFIIH and P-TEFb coordinate transcription with capping enzyme recruitment at specific genes in fission yeast. Mol Cell. 2009;33:738–751.
   PubMed Web of Science ®Google Scholar
• Wong KH, Jin Y, Struhl K. TFIIH phosphorylation of the Pol II CTD stimulates mediator dissociation from the preinitiation complex and promoter escape. Mol Cell. 2014;54:601–612.
   PubMed Web of Science ®Google Scholar
• Boehning M, Dugast-Darzacq C, Rankovic M, et al. RNA polymerase II clustering through carboxy-terminal domain phase separation. Nat Struct Mol Biol. 2018;25:833–840.
   PubMed Web of Science ®Google Scholar
• Knight ZA, Shokat KM. Chemical genetics: where genetics and pharmacology meet. Cell. 2007;128:425–430.
   PubMed Web of Science ®Google Scholar
• Hong SW, Hong SM, Yoo JW, et al. Phosphorylation of the RNA polymerase II C-terminal domain by TFIIH kinase is not essential for transcription of Saccharomyces cerevisiae genome. Proc Natl Acad Sci U S A. 2009;106:14276–14280.
   PubMed Web of Science ®Google Scholar
• Liu Y, Kung C, Fishburn J, et al. Two cyclin-dependent kinases promote RNA polymerase II transcription and formation of the scaffold complex. Mol Cell Biol. 2004;24:1721–1735.
   PubMed Web of Science ®Google Scholar
• Booth GT, Parua PK, Sanso M, et al. Cdk9 regulates a promoter-proximal checkpoint to modulate RNA polymerase II elongation rate in fission yeast. Nat Commun. 2018;9:543.
   PubMed Web of Science ®Google Scholar
• Devos M, Mommaerts E, Migeot V, et al. Fission yeast Cdk7 controls gene expression through both its CAK and C-terminal domain kinase activities. Mol Cell Biol. 2015;35:1480–1490.
   PubMed Web of Science ®Google Scholar
• Larochelle S, Batliner J, Gamble MJ, et al. Dichotomous but stringent substrate selection by the dual-function Cdk7 complex revealed by chemical genetics. Nat Struct Mol Biol. 2006;13:55–62.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Molina JB, Tseng SC, Simonett SP, et al. Engineered covalent inactivation of TFIIH-kinase reveals an elongation checkpoint and results in widespread mRNA stabilization. Mol Cell. 2016;63:433–444.
   PubMed Web of Science ®Google Scholar
• Chipumuro E, Marco E, Christensen CL, et al. CDK7 inhibition suppresses super-enhancer-linked oncogenic transcription in MYCN-driven cancer. Cell. 2014;159:1126–1139.
   PubMed Web of Science ®Google Scholar
• Christensen CL, Kwiatkowski N, Abraham BJ, et al. Targeting transcriptional addictions in small cell lung cancer with a covalent CDK7 inhibitor. Cancer Cell. 2014;26:909–922.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang T, Kwiatkowski N, et al. CDK7-dependent transcriptional addiction in triple-negative breast cancer. Cell. 2015;163:174–186.
   PubMed Web of Science ®Google Scholar
• Kalan S, Amat R, Schachter MM, et al. Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors. Cell Rep. 2017;21:467–481.
   PubMed Web of Science ®Google Scholar
• Moteki S, Price D. Functional coupling of capping and transcription of mRNA. Mol Cell. 2002;10:599–609.
   PubMed Web of Science ®Google Scholar
• Cho EJ, Takagi T, Moore CR, et al. mRNA capping enzyme is recruited to the transcription complex by phosphorylation of the RNA polymerase II carboxy-terminal domain. Genes Dev. 1997;11:3319–3326.
   PubMed Web of Science ®Google Scholar
• McCracken S, Fong N, Rosonina E, et al. 5´-Capping enzymes are targeted to pre-mRNA by binding to the phosphorylated carboxy-terminal domain of RNA polymerase II. Genes Dev. 1997;11:3306–3318.
   PubMed Web of Science ®Google Scholar
• Schwer B, Shuman S. Deciphering the RNA polymerase II CTD code in fission yeast. Mol Cell. 2011;43:311–318.
   PubMed Web of Science ®Google Scholar
• Ho CK, Shuman S. Distinct roles for CTD Ser-2 and Ser-5 phosphorylation in the recruitment and allosteric activation of mammalian mRNA capping enzyme. Mol Cell. 1999;3:405–411.
   PubMed Web of Science ®Google Scholar
• Schroeder SC, Schwer B, Shuman S, et al. Dynamic association of capping enzymes with transcribing RNA polymerase II. Genes Dev. 2000;14:2435–2440.
   PubMed Web of Science ®Google Scholar
• Ebmeier CC, Erickson B, Allen BL, et al. Human TFIIH kinase CDK7 regulates transcription-associated chromatin modifications. Cell Rep. 2017;20:1173–1186.
   PubMed Web of Science ®Google Scholar
• Guiguen A, Soutourina J, Dewez M, et al. Recruitment of P-TEFb (Cdk9-Pch1) to chromatin by the cap-methyl transferase Pcm1 in fission yeast. Embo J. 2007;26:1552–1559.
   PubMed Web of Science ®Google Scholar
• Noe Gonzalez M, Sato S, Tomomori-Sato C, et al. CTD-dependent and -independent mechanisms govern co-transcriptional capping of Pol II transcripts. Nat Commun. 2018;9:3392.
   PubMed Web of Science ®Google Scholar
• Kelso TW, Baumgart K, Eickhoff J, et al. Cyclin-dependent kinase 7 controls mRNA synthesis by affecting stability of preinitiation complexes, leading to altered gene expression, cell cycle progression, and survival of tumor cells. Mol Cell Biol. 2014;34:3675–3688.
   PubMed Web of Science ®Google Scholar
• Booth GT, Wang IX, Cheung VG, et al. Divergence of a conserved elongation factor and transcription regulation in budding and fission yeast. Genome Res. 2016;26:799–811.
   PubMed Web of Science ®Google Scholar
• Adelman K, Lis JT. Promoter-proximal pausing of RNA polymerase II: emerging roles in metazoans. Nat Rev Genet. 2012;13:720–731.
   PubMed Web of Science ®Google Scholar
• Perales R, Bentley D. “Cotranscriptionality”: the transcription elongation complex as a nexus for nuclear transactions. Mol Cell. 2009;36:178–191.
   PubMed Web of Science ®Google Scholar
• Bernecky C, Plitzko JM, Cramer P. Structure of a transcribing RNA polymerase II-DSIF complex reveals a multidentate DNA-RNA clamp. Nat Struct Mol Biol. 2017;24:809–815.
   PubMed Web of Science ®Google Scholar
• Ehara H, Yokoyama T, Shigematsu H, et al. Structure of the complete elongation complex of RNA polymerase II with basal factors. Science. 2017;357:921–924.
   PubMed Web of Science ®Google Scholar
• Grohmann D, Nagy J, Chakraborty A, et al. The initiation factor tfe and the elongation factor Spt4/5 compete for the RNAP clamp during transcription initiation and elongation. Mol Cell. 2011;43:263–274.
   PubMed Web of Science ®Google Scholar
• Klein BJ, Bose D, Baker KJ, et al. RNA polymerase and transcription elongation factor Spt4/5 complex structure. Proc Natl Acad Sci U S A. 2011;108:546–550.
   PubMed Web of Science ®Google Scholar
• Martinez-Rucobo FW, Sainsbury S, Cheung AC, et al. Architecture of the RNA polymerase-Spt4/5 complex and basis of universal transcription processivity. Embo J. 2011;30:1302–1310.
   PubMed Web of Science ®Google Scholar
• Vos SM, Farnung L, Boehning M, et al. Structure of activated transcription complex Pol II-DSIF-PAF-SPT6. Nature. 2018;560:607–612.
   PubMed Web of Science ®Google Scholar
• Vos SM, Farnung L, Urlaub H, et al. Structure of paused transcription complex Pol II-DSIF-NELF. Nature. 2018;560:601–606.
   PubMed Web of Science ®Google Scholar
• Jonkers I, Kwak H, Lis JT. Genome-wide dynamics of Pol II elongation and its interplay with promoter proximal pausing, chromatin, and exons. Elife. 2014;3:e02407.
   PubMed Web of Science ®Google Scholar
• Peterlin BM, Price DH. Controlling the elongation phase of transcription with P-TEFb. Mol Cell. 2006;23:297–305.
   PubMed Web of Science ®Google Scholar
• Sanso M, Levin RS, Lipp JJ, et al. P-TEFb regulation of transcription termination factor Xrn2 revealed by a chemical genetic screen for Cdk9 substrates. Genes Dev. 2016;30:117–131.
   PubMed Web of Science ®Google Scholar
• Ohkuma Y, Roeder RG. Regulation of TFIIH ATPase and kinase activities by TFIIE during active initiation complex formation. Nature. 1994;368:160–163.
   PubMed Web of Science ®Google Scholar
• Dominski Z, Marzluff WF. Formation of the 3´ end of histone mRNA: getting closer to the end. Gene. 2007;396:373–390.
   PubMed Web of Science ®Google Scholar
• Narita T, Yung TM, Yamamoto J, et al. NELF interacts with CBC and participates in 3´ end processing of replication-dependent histone mRNAs. Mol Cell. 2007;26:349–365.
   PubMed Web of Science ®Google Scholar
• Pirngruber J, Shchebet A, Schreiber L, et al. CDK9 directs H2B monoubiquitination and controls replication-dependent histone mRNA 3´-end processing. EMBO Rep. 2009;10:894–900.
   PubMed Web of Science ®Google Scholar
• Laitem C, Zaborowska J, Isa NF, et al. CDK9 inhibitors define elongation checkpoints at both ends of RNA polymerase II-transcribed genes. Nat Struct Mol Biol. 2015;22:396–403.
   PubMed Web of Science ®Google Scholar
• Bartkowiak B, Liu P, Phatnani HP, et al. CDK12 is a transcription elongation-associated CTD kinase, the metazoan ortholog of yeast Ctk1. Genes Dev. 2010;24:2303–2316.
   PubMed Web of Science ®Google Scholar
• Davidson L, Muniz L, West S. 3´ end formation of pre-mRNA and phosphorylation of Ser2 on the RNA polymerase II CTD are reciprocally coupled in human cells. Genes Dev. 2014;28:342–356.
   PubMed Web of Science ®Google Scholar
• Bosken CA, Farnung L, Hintermair C, et al. The structure and substrate specificity of human Cdk12/Cyclin K. Nat Commun. 2014;5:3505.
   PubMed Web of Science ®Google Scholar
• Greifenberg AK, Honig D, Pilarova K, et al. Structural and functional analysis of the Cdk13/Cyclin K complex. Cell Rep. 2016;14:320–331.
   PubMed Web of Science ®Google Scholar
• Chu Y, Sutton A, Sternglanz R, et al. The BUR1 cyclin-dependent protein kinase is required for the normal pattern of histone methylation by SET2. Mol Cell Biol. 2006;26:3029–3038.
   PubMed Web of Science ®Google Scholar
• Laribee RN, Krogan NJ, Xiao T, et al. BUR kinase selectively regulates H3 K4 trimethylation and H2B ubiquitylation through recruitment of the PAF elongation complex. Curr Biol. 2005;15:1487–1493.
   PubMed Web of Science ®Google Scholar
• Sansó M, Lee KM, Viladevall L, et al. A positive feedback loop links opposing functions of P-TEFb/Cdk9 and histone H2B ubiquitylation to regulate transcript elongation in fission yeast. PLoS Genet. 2012;8:e1002822.
   PubMed Web of Science ®Google Scholar
• Wood A, Schneider J, Dover J, et al. The Bur1/Bur2 complex is required for histone H2B monoubiquitination by Rad6/Bre1 and histone methylation by COMPASS. Mol Cell. 2005;20:589–599.
   PubMed Web of Science ®Google Scholar
• Mbogning J, Page V, Burston J, et al. Functional interaction of Rpb1 and Spt5 C-terminal domains in co-transcriptional histone modification. Nucleic Acids Res. 2015.
   PubMed Web of Science ®Google Scholar
• Malumbres M, Barbacid M. Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer. 2009;9:153–166.
   PubMed Web of Science ®Google Scholar
• Hnisz D, Abraham BJ, Lee TI, et al. Super-enhancers in the control of cell identity and disease. Cell. 2013;155:934–947.
   PubMed Web of Science ®Google Scholar
• Loven J, Hoke HA, Lin CY, et al. Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell. 2013;153:320–334.
   PubMed Web of Science ®Google Scholar
• O’Neil NJ, Bailey ML, Hieter P. Synthetic lethality and cancer. Nat Rev Genet. 2017;18:613–623.
   PubMed Web of Science ®Google Scholar
• Cao K, Shilatifard A. Inhibit globally, act locally: CDK7 inhibitors in cancer therapy. Cancer Cell. 2014;26:158–159.
   PubMed Web of Science ®Google Scholar
• Hong H, Zeng Y, Jian W, et al. CDK7 inhibition suppresses rheumatoid arthritis inflammation via blockage of NF-kappaB activation and IL-1beta/IL-6 secretion. J Cell Mol Med. 2018;22:1292–1301.
   PubMed Web of Science ®Google Scholar
• Xia Y, Lin LY, Liu ML, et al. Selective inhibition of CDK7 ameliorates experimental arthritis in mice. Clin Exp Med. 2015;15:269–275.
   PubMed Web of Science ®Google Scholar
• Schachter MM, Merrick KA, Larochelle S, et al. A cdk7-cdk4 T-loop phosphorylation cascade promotes g1 progression. Mol Cell. 2013;50:250–260.
   PubMed Web of Science ®Google Scholar
• Larochelle S, Chen J, Knights R, et al. T-loop phosphorylation stabilizes the CDK7-cyclin H-MAT1 complex in vivo and regulates its CTD kinase activity. Embo J. 2001;20:3749–3759.
   PubMed Web of Science ®Google Scholar
• Zhang T, Kwiatkowski N, Olson CM, et al. Covalent targeting of remote cysteine residues to develop CDK12 and CDK13 inhibitors. Nat Chem Biol. 2016;12:876–884.
   PubMed Web of Science ®Google Scholar